Viewing nowCrosstein 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201707534 · Approved 2017.10.20 · Insurance code 693902690
Improvement of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular diseases
This medication helps lower blood cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are insufficient. It can be used as an adjunct to diet therapy or other treatments in patients with familial hypercholesterolemia. Additionally, it has the effect of lowering total cholesterol and LDL cholesterol levels in hypercholesterolemic patients, thus delaying the progression of atherosclerosis. It is also safely used in children and adolescents meeting specific criteria for familial hypercholesterolemia and as an adjunct to diet therapy in patients with dysbetalipoproteinemia. Furthermore, it helps reduce the risks associated with stroke, myocardial infarction, and vascular revascularization in adults with a high risk of cardiovascular disease. Therefore, this medication is used for the treatment of several diseases associated with dyslipidemia and the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Pediatric patients with heterozygous familial hypercholesterolemia (10 to 17 years of age): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, patients with allergies to this medication's ingredients, severe liver dysfunction, muscle disorders, as well as pregnant or breastfeeding women should not take this medication. Patients with severely impaired kidney function or those taking certain medications also need to be cautious. Notably, patients at high risk for muscle-related side effects should not take the 40 mg dose of this medication. It is important to regularly check liver function and muscle condition before and while taking this medication. If symptoms such as muscle pain or weakness occur, immediate consultation with a physician is necessary. Patients who consume large amounts of alcohol or have a history of liver disease should also exercise caution while taking this medication, and those with hypothyroidism or nephrotic syndrome should use this medication only after treating the underlying causes. This medication contains lactose and is unsuitable for patients with lactose intolerance. This medication may interact with other drugs, so it is crucial to inform your physician or pharmacist if you are taking other medications. Particularly, the risk of muscle side effects may increase when combined with certain antiviral agents, immunosuppressants, antifungals, and antibiotics. Women of childbearing potential should use appropriate contraception before taking this medication and should not take it during pregnancy. Adverse reactions during use may include headache, dizziness, muscle pain, gastrointestinal disturbances, and in rare cases, severe liver damage or muscle rupture. In cases of overdose, there is no specific antidote, and treatment should be symptomatic and include liver and muscle function tests. Patients should be aware that dizziness may occur while driving or operating machinery. This medication may have higher plasma concentrations in Asians, necessitating dose adjustments. All these considerations must be followed for safe and effective treatment, and it is important to adequately consult with healthcare professionals before and during use.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature of 1 to 30 degrees Celsius in a cool, dry place. This will help preserve the medication's effectiveness for a longer period.
Pink round film-coated tablet
28 tablets (14 tablets/PTP*2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.